Subscribe to Newsletter

Standards & Regulation

Business & Regulation Standards & Regulation

UK Launches Seven New Centres for Regulatory Science and Innovation

| Stephanie Vine | 3 min read

A regulatory science push in the UK includes centres for digital transformation, AI and more.

Business & Regulation Standards & Regulation

RFK Jr’s Speech Leaks: Vaccines, Autism, and Chronic Illness

| Stephanie Vine | 3 min read

Robert F Kennedy Jr’s recent speech suggests that investigations into childhood vaccines and over-medication could be on the cards.

Business & Regulation Standards & Regulation

AMF’s 2026 AMR Strategy, Revealed

| Rob Coker | 3 min read

The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.

Business & Regulation Business Practice

GenAI: Automating Regulatory Submissions

| Agnes Cwienczek | 4 min read

Within two years, pharma companies may be able to rely on technology to automatically create and cross-check entire regulatory submissions.

Business & Regulation Standards & Regulation

Researchers Respond to NIH Funding Cuts

| Stephanie Vine | 4 min read

Stakeholders explain why the NIH’s move to cap indirect costs associated with research grants could damage medical innovation.

Business & Regulation Standards & Regulation

Trump’s Tariffs

| Rob Coker | 3 min read

US-based pharmaceutical associations fear the supply chain repercussions of tariffs, and offer advice for a more sustainable alternative.

Business & Regulation Bioprocessing - Upstream & Downstream

Sanofi’s Push for Pricing Flexibility in the UK

| 6 min read

We speak with Sanofi’s Anju Bhalla about its appeal against NICE’s final draft guidance for Sarclisa.

Business & Regulation Standards & Regulation

Robert F. Kennedy Jr Nomination Advances

| Stephanie Vine | 2 min read

Senate committee votes in favor of the nomination; full Senate vote will be next.

Business & Regulation Standards & Regulation

Panic in US Science

| Stephanie Vine | 3 min read

The Trump administration’s move to pause federal funding while projects are vetted causes concern and lawsuits

Business & Regulation Standards & Regulation

Preparing for the Next Trump Presidency

| 6 min read

What can we expect the US life sciences sector to look like over the course of the next four years as Donald Trump takes up his presidency?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register